Related by context. Frequent words. (Click for all words.) 85 submitted Marketing Authorization 76 Application BLA 74 Application MAA 72 FDA Accepts 70 Initiates Phase II 68 Presents Positive 67 NASDAQ CRXL 67 Crucell NV Euronext 66 Completes Enrollment 66 Receives Patent 66 Inc Therapeutic Competitors 66 Act PDUFA date 65 Patent Issued 65 Inc. Nasdaq IMGN 65 FDA Clears 65 Develop Novel 65 See BioWorld Today 64 ZALBIN 64 Initiates Phase 64 Files Patent 64 Initiate Phase 64 Inc. Nasdaq SEPR 64 Drug Candidate 64 Company Nasdaq PRGO 63 Report companiesandmarkets.com adds 63 Generic Version 63 LYON France BUSINESS WIRE 63 Nasdaq VRTX 63 Patient Enrollment 63 Announces FDA Clearance 62 Receives FDA Clearance 62 Pivotal Phase III 62 Recombinant Human 62 NASDAQ SHPGY 62 supplemental Biologics License Application 62 Surgical Adhesive 62 Barrier Therapeutics Inc. 62 Positive Opinion 62 DRRX 62 Clinical Trial Results 62 Patent Covering 62 HAYWARD Calif. BUSINESS WIRE 62 Announces Initiation 61 ALAMEDA Calif. BUSINESS WIRE 61 refractory chronic lymphocytic 61 Nasdaq ENZN 61 R sorafenib tablets 61 Idera Pharmaceuticals 61 High Growth Forecasted 61 Develop Next Generation 61 Announces Immediate Availability 61 Connetics Corporation 61 Monoclonal Antibody 61 Orphan Drug designation 61 Files Shelf Registration Statement 60 Q2 Loss Narrows 60 Marketing Authorisation 60 Single Dose 60 Achieves Milestone 60 Transcept Pharmaceuticals 60 EPIX Pharmaceuticals Inc. 60 Phase III Clinical Trial 60 Hold Fourth Quarter 60 Protects Against 60 Q2 Loss Widens 60 Clinical Trials Update 60 Launches Next Generation 60 Updates Guidance 60 Calls Purchased 60 NASDAQ LGND 60 MORRISVILLE NC BUSINESS WIRE 60 Awarded Patent 60 Inc. NASDAQ MRNA 60 Preclinical Data 59 Marketing Authorization Application MAA 59 MARLBOROUGH Mass. BUSINESS WIRE 59 Kuvan R 59 Significantly Reduces 59 IMPAX Laboratories Inc. 59 RNAi Therapeutics 59 Fibrocell Science Inc. 59 Shows Promise 59 Belimumab 59 candidate brentuximab vedotin 59 NASDAQ IMCL 59 Options Trader Alert 59 Panzem R 59 Cholesterol Drug 59 Signs Licensing Agreement 59 FDA Orphan Drug 59 Extends Leadership 59 NASDAQ OSIR 59 Webcast Annual Meeting 59 BPAX 59 Provides Guidance 59 ALIM 59 www.gsk.com 58 Significantly Improves 58 Receives Positive 58 Introduces Enhanced 58 AP PhotoExpress Network